Clinical Trial
Published on 18 Mar 2022
A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis
in Multiple Sclerosis and Neuroimmunology

- 5,605 views
- 4 citations
Clinical Trial
Published on 18 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Review
Published on 17 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 17 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 15 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 15 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 11 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Review
Published on 10 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Review
Published on 10 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Review
Published on 09 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Review
Published on 09 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 09 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Review
Published on 09 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 07 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Original Research
Published on 07 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Mini Review
Published on 07 Mar 2022
in Multiple Sclerosis and Neuroimmunology

Review
Published on 04 Mar 2022
in Multiple Sclerosis and Neuroimmunology
